Similarities between Alemtuzumab and Multiple sclerosis
Alemtuzumab and Multiple sclerosis have 5 things in common (in Unionpedia): Autoimmune disease, Interferon beta-1a, Intravenous therapy, Lymphocyte, Monoclonal antibody.
Autoimmune disease
An autoimmune disease is a condition arising from an abnormal immune response to a normal body part.
Alemtuzumab and Autoimmune disease · Autoimmune disease and Multiple sclerosis ·
Interferon beta-1a
Interferon beta-1a (also interferon beta 1-alpha) is a cytokine in the interferon family used to treat multiple sclerosis (MS).
Alemtuzumab and Interferon beta-1a · Interferon beta-1a and Multiple sclerosis ·
Intravenous therapy
Intravenous therapy (IV) is a therapy that delivers liquid substances directly into a vein (intra- + ven- + -ous).
Alemtuzumab and Intravenous therapy · Intravenous therapy and Multiple sclerosis ·
Lymphocyte
A lymphocyte is one of the subtypes of white blood cell in a vertebrate's immune system.
Alemtuzumab and Lymphocyte · Lymphocyte and Multiple sclerosis ·
Monoclonal antibody
Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell.
Alemtuzumab and Monoclonal antibody · Monoclonal antibody and Multiple sclerosis ·
The list above answers the following questions
- What Alemtuzumab and Multiple sclerosis have in common
- What are the similarities between Alemtuzumab and Multiple sclerosis
Alemtuzumab and Multiple sclerosis Comparison
Alemtuzumab has 38 relations, while Multiple sclerosis has 242. As they have in common 5, the Jaccard index is 1.79% = 5 / (38 + 242).
References
This article shows the relationship between Alemtuzumab and Multiple sclerosis. To access each article from which the information was extracted, please visit: